50.44
Schlusskurs vom Vortag:
$50.40
Offen:
$50.52
24-Stunden-Volumen:
377.20K
Relative Volume:
0.41
Marktkapitalisierung:
$1.37B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.41%
1M Leistung:
-12.48%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Hinge Health Inc Stock (HNGE) Company Profile
Firmenname
Hinge Health Inc
Sektor
Branche
Telefon
415-689-8429
Adresse
455 MARKET STREET, SAN FRANCISCO
Vergleichen Sie HNGE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
HNGE
Hinge Health Inc
|
50.44 | 3.95B | 0 | 0 | 0 | 0.00 |
![]()
VEEV
Veeva Systems Inc
|
287.65 | 46.89B | 2.97B | 809.93M | 1.33B | 4.8743 |
![]()
TEM
Tempus Ai Inc
|
89.87 | 16.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
67.03 | 12.64B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
94.04 | 8.03B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
36.62 | 6.90B | 906.14M | -52.62M | 89.62M | -0.3621 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-05 | Eingeleitet | Robert W. Baird | Neutral |
2025-07-14 | Eingeleitet | Citizens JMP | Mkt Outperform |
2025-06-16 | Eingeleitet | Barclays | Overweight |
2025-06-16 | Eingeleitet | BofA Securities | Buy |
2025-06-16 | Eingeleitet | Canaccord Genuity | Buy |
2025-06-16 | Eingeleitet | Evercore ISI | Outperform |
2025-06-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2025-06-16 | Eingeleitet | Morgan Stanley | Overweight |
2025-06-16 | Eingeleitet | Needham | Buy |
2025-06-16 | Eingeleitet | Piper Sandler | Overweight |
2025-06-16 | Eingeleitet | RBC Capital Mkts | Outperform |
2025-06-16 | Eingeleitet | Raymond James | Outperform |
2025-06-16 | Eingeleitet | Stifel | Buy |
2025-06-16 | Eingeleitet | Truist | Buy |
2025-06-16 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Hinge Health Inc Aktie (HNGE) Neueste Nachrichten
Hinge Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating - TipRanks
How Hinge Health Inc. Class stock trades after rate cutsInsider Selling & Weekly Top Gainers Trade List - newser.com
Will Hinge Health Inc. Class stock outperform benchmarksMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com
Can Hinge Health Inc. Class stock deliver consistent EPS growthWeekly Profit Analysis & AI Powered Market Entry Strategies - newser.com
What insider purchases suggest about Hinge Health Inc. Class stockTrade Analysis Summary & Short-Term High Return Strategies - newser.com
Will Hinge Health Inc. Class stock attract long term capital inflowsMarket Risk Summary & Reliable Intraday Trade Alerts - newser.com
Hinge Health (NYSE:HNGE) Given Sell (D) Rating at Weiss Ratings - MarketBeat
Can Hinge Health Inc. Class stock ride next bull market cycleEarnings Recap Report & Verified Chart Pattern Trade Signals - newser.com
Hinge Health Shares Surge Amid Analyst Optimism - TipRanks
Hinge Health, Inc. Class A Common Stock (NYSE:HNGE) Stock Quote | FinancialContent - FinancialContent
Hinge Health (HNGE): Evaluating Valuation After Recent Share Price Momentum and Growth Outlook Shift - Yahoo Finance
Will Hinge Health Inc. Class stock rise with strong economy2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
Hinge Health: Experiencing Both Growth And Significant Risks, Hold Ahead Of Q3 Earnings - Seeking Alpha
Hinge Health IPO Date, Price, Terms, and Performance - Access IPOs
CHURCHILL MANAGEMENT Corp Takes Position in Hinge Health Inc. $HNGE - MarketBeat
Jim Cramer Says if Hinge Health Comes Down a Little More He “Would Buy More” - MSN
Hinge Health to announce third quarter 2025 financial results on November 4, 2025 - The Joplin Globe
Strong Buy Recommendation for Hinge Health, Inc. Amid Market Underestimation and Strategic Growth Potential - TipRanks
Hinge Health Jumps 17% After Top-Priced $437 Million IPO - MSN
Trump Administration Review Targets Medical Supply ChainBecton Dickinson (NYSE:BDX), Baxter Intl (NYSE:BAX) - Benzinga
Hinge Health (NYSE:HNGE) Shares Down 6.3%Here's What Happened - MarketBeat
AI Helps Hinge Health Get Closer To Profit Margins Goal - Finimize
Hinge Health Inc. (NYSE:HNGE) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Hinge Health Likely to Hit 85% Gross Margin by 2027, Morgan Stanley Says - MarketScreener
Morgan Stanley Raises Price Target on Hinge Health to $67 From $57, Keeps Overweight Rating - MarketScreener
Stifel Raises Hinge Health (HNGE) PT to $66 on Strong Business Momentum, Product Innovation - Insider Monkey
Hinge Health IPO attracts more orders for shares than available: report - MSN
Finanzdaten der Hinge Health Inc-Aktie (HNGE)
Es liegen keine Finanzdaten für Hinge Health Inc (HNGE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):